These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles. Liu Q; Li R; Zhu Z; Qian X; Guan W; Yu L; Yang M; Jiang X; Liu B Int J Pharm; 2012 Jul; 430(1-2):350-8. PubMed ID: 22525076 [TBL] [Abstract][Full Text] [Related]
23. [Preparation of paclitaxel-loaded chitosan polymeric micelles and influence of surface charges on their tissue biodistribution in mice]. Huo MR; Zhou JP; Wei Y; Lü L Yao Xue Xue Bao; 2006 Sep; 41(9):867-72. PubMed ID: 17111835 [TBL] [Abstract][Full Text] [Related]
24. Anti-tumor activity of paclitaxel through dual-targeting carrier of cyclic RGD and transferrin conjugated hyperbranched copolymer nanoparticles. Xu Q; Liu Y; Su S; Li W; Chen C; Wu Y Biomaterials; 2012 Feb; 33(5):1627-39. PubMed ID: 22118775 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646 [TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles. Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175 [TBL] [Abstract][Full Text] [Related]
27. Biocompatibility, cellular uptake and biodistribution of the polymeric amphiphilic nanoparticles as oral drug carriers. Liu Y; Kong M; Feng C; Yang KK; Li Y; Su J; Cheng XJ; Park HJ; Chen XG Colloids Surf B Biointerfaces; 2013 Mar; 103():345-53. PubMed ID: 23247264 [TBL] [Abstract][Full Text] [Related]
28. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers. He M; Zhao Z; Yin L; Tang C; Yin C Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302 [TBL] [Abstract][Full Text] [Related]
29. Design and characterization of antitumor drug paclitaxel-loaded chitosan nanoparticles by W/O emulsions. Xu J; Ma L; Liu Y; Xu F; Nie J; Ma G Int J Biol Macromol; 2012 Mar; 50(2):438-43. PubMed ID: 22230611 [TBL] [Abstract][Full Text] [Related]
30. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988 [TBL] [Abstract][Full Text] [Related]
31. Paclitaxel-loaded Pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. Oh KS; Song JY; Cho SH; Lee BS; Kim SY; Kim K; Jeon H; Kwon IC; Yuk SH J Control Release; 2010 Dec; 148(3):344-50. PubMed ID: 20797418 [TBL] [Abstract][Full Text] [Related]
32. [Synthesis and characterization of folic acid-conjugated chitosan nanoparticles as a tumor-targeted drug carrier]. Gong JL; Wang SM; Hu XG; Cao MM; Zhang JR Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2183-6. PubMed ID: 19114352 [TBL] [Abstract][Full Text] [Related]
33. Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX. Wang F; Zhang D; Zhang Q; Guo S; Zheng D; Hao L; Guo H; Li C J Drug Target; 2013 Feb; 21(2):137-45. PubMed ID: 23046502 [TBL] [Abstract][Full Text] [Related]
34. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation. Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Huo M; Zhang Y; Zhou J; Zou A; Yu D; Wu Y; Li J; Li H Int J Pharm; 2010 Jul; 394(1-2):162-73. PubMed ID: 20457237 [TBL] [Abstract][Full Text] [Related]
36. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution. Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497 [TBL] [Abstract][Full Text] [Related]
37. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect. Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342 [TBL] [Abstract][Full Text] [Related]
38. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946 [TBL] [Abstract][Full Text] [Related]
39. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163 [TBL] [Abstract][Full Text] [Related]
40. Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery. Yoon HY; Koo H; Choi KY; Chan Kwon I; Choi K; Park JH; Kim K Biomaterials; 2013 Jul; 34(21):5273-80. PubMed ID: 23591396 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]